Navellier & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Buy
5,528
+97
+2% +$11K 0.06% 198
2025
Q4
$680K Hold
5,431
0.08% 183
2025
Q3
$727K Hold
5,431
0.07% 212
2025
Q2
$739K Hold
5,431
0.09% 169
2025
Q1
$720K Sell
5,431
-156
-3% -$19.9K 0.1% 166
2024
Q4
$632K Sell
5,587
-1,273
-19% -$147K 0.08% 217
2024
Q3
$782K Hold
6,860
0.11% 169
2024
Q2
$713K Sell
6,860
-57
-0.8% -$6.04K 0.08% 193
2024
Q1
$786K Hold
6,917
0.1% 180
2023
Q4
$761K Buy
6,917
+57
+0.8% +$5.7K 0.11% 169
2023
Q3
$664K Buy
+6,860
New +$720K 0.11% 177

Other funds holding ABT

Navellier & Associates's ABT Position: Q1 2026 in Review

Navellier & Associates increased its Abbott (ABT) stake by 1.8% in Q1 2026, buying an estimated $11K and bringing the position to 5,528 shares worth $568K. The position accounts for 0.06% of the portfolio, ranked #198.

Navellier & Associates first reported a position in ABT in Q3 2023 and has held it in 11 quarters since. The position peaked at $786K in Q1 2024. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Navellier & Associates held 5,528 shares of Abbott worth $568K as of Q1 2026.
  • Navellier & Associates bought 97 Abbott shares in Q1 2026, an estimated $11K.
  • Abbott made up 0.06% of Navellier & Associates's portfolio in Q1 2026, its #198 holding.
  • Navellier & Associates first reported a position in Abbott in Q3 2023 and has held it in 11 quarters since.
  • Navellier & Associates's Abbott position peaked at $786K in Q1 2024.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.